A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
NCT: NCT07187297 · RECRUITING
Advertisement
NCT IDNCT07187297
StatusRECRUITING
Start Date2025-10-31
SponsorBausch Health Americas, Inc. (INDUSTRY)
First posted
Last updated
Brief Summary
A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.